Condition
Mental Impairment
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04254562Not ApplicableCompletedPrimary
Helping Youth on the Path to Employment
NCT06067373UnknownPrimary
Impact and Burden of Postponing Elective Surgeries
NCT03682263Not ApplicableCompletedPrimary
Supported Employment Demonstration
NCT04463784Not ApplicableUnknown
Efficacy of Efavirenz 400mg vs. 600mg Combined With Lamivudine and Tenofovir in Treatment Naive HIV Infection
NCT03222596Not ApplicableCompleted
The Impact of Exercise Training on Living Quality in Multiple Sclerosis Individuals
Showing all 5 trials